Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society

Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society

Bibliographic Details
Main Authors:	Aditya Kapoor, Ulhas Pandurangi, Vanita Arora, Anoop Gupta, Aparna Jaswal, Ashish Nabar, Ajay Naik, Nitish Naik, Narayanan Namboodiri, Amit Vora, Rakesh Yadav, Anil Saxena
Format:	Article
Language:	English
Published:	Elsevier 2020-05-01
Series:	Indian Pacing and Electrophysiology Journal
Subjects:	Hydroxychloroquine COVID-19 QTc interval Torsade de pointes Heart disease
Online Access:	http://www.sciencedirect.com/science/article/pii/S0972629220300383

Similar Items

Which QTc correction formulae (Bazett, Framingham, or Fridericia) to use for Hydroxychloroquine induced QTc prolongation?
by: Anunay Gupta, et al.
Published: (2020-09-01)

QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment
by: Sarah Grewal, et al.
Published: (2020-09-01)

QTc interval of healthcare workers from India: Baseline and effect of hydroxychloroquine prophylaxis during the COVID-19 pandemic
by: Shreyas Gutte, et al.
Published: (2023-01-01)

Hydroxychloroquine and QTc: beyond COVID-19
by: Alberto Castagna, et al.
Published: (2020-10-01)

Early Alterations of QTc in Patients with COVID-19 Treated with Hydroxychloroquine or Chloroquine in Libreville, Gabon
by: Elsa Ayo Bivigou, et al.
Published: (2022-06-01)

Risperidone alone did not induce torsade de pointes: Experimental evidence from the chronic atrioventricular block model dogs
by: Yoshio Nunoi, et al.
Published: (2020-08-01)

Hydroxychloroquine use is not associated with QTc length in a large cohort of SLE and RA patients
by: Elizabeth Park, et al.
Published: (2021-10-01)

Effects of cardiac toxicity of combination therapy with hydroxychloroquine and azithromycin in COVID-19 patients
by: Usha Yendrapalli, et al.
Published: (2021-11-01)

Hydroxychloroquine use in hospitalised patients with COVID-19: An observational matched cohort study
by: Markos Kalligeros, et al.
Published: (2020-09-01)

Effect of Hydroxychloroquine on QTc in Patients Diagnosed with COVID-19: A Systematic Review and Meta-Analysis
by: Angelos Arfaras-Melainis, et al.
Published: (2021-05-01)

Safety and Effectiveness of Hydroxychloroquine and Azithromycin Combination Therapy for Treatment of Hospitalized Patients with COVID-19: A Propensity-Matched Study
by: Henry D. Huang, et al.
Published: (2020-10-01)

A Pharmacovigilance Study of Hydroxychloroquine Cardiac Safety Profile: Potential Implication in COVID-19 Mitigation
by: Anand Prakash Singh, et al.
Published: (2020-06-01)

Cardiovascular Safety of Hydroxychloroquine–Azithromycin in 424 COVID-19 Patients
by: Matthieu Million, et al.
Published: (2023-04-01)

Dose-dependent QTc interval prolongation under haloperidol and pipamperone in the management of delirium in a naturalistic setting
by: Philipp Bohny, et al.
Published: (2023-10-01)

Late presentation of Torsades de Pointes related to fluoxetine following a multiple drug overdose
by: Jan Albert Nicolaas Groot, et al.
Published: (2018-09-01)

Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients
by: Vincenzo Russo, et al.
Published: (2020-10-01)

QTc prolongation during the SARS-CoV-2 outbreak: clinical risk management through hospital training course, focus on elderly patients
by: Nicola Forni, et al.
Published: (2020-08-01)

QTc Interval Reference Values and Their (Non)-Maturational Factors in Neonates and Infants: A Systematic Review
by: Lisa De Smet, et al.
Published: (2022-11-01)

Hydroxychloroquine as Prophylaxis for COVID-19: A Review
by: Manuela Monti, et al.
Published: (2020-12-01)

Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
by: Praveen Balabaskaran Nina, et al.
Published: (2020-01-01)

The COVID-19 hydroxychloroquine prophylaxis perception of Indian anesthesiologists: A survey-based original article
by: Shagun B Shah, et al.
Published: (2020-01-01)

Case report: Ivabradine induced Torsades de Pointes
by: Mohit M. Bhagwati, et al.
Published: (2023-01-01)

PONV management in patients with QTc prolongation on the EKG
by: S. Soghomonyan, et al.
Published: (2021-01-01)

Dose-Dependent Effects of Methadone on QT interval in Patients under Methadone Maintenance Treatment
by: Farzad Gheshlaghi, et al.
Published: (2013-03-01)

Hydroxychloroquine and chloroquine in prophylaxis and treatment of COVID-19: What is known?
by: Pathiyil Ravi Shankar, et al.
Published: (2021-01-01)

Prevalence of Medication Associated with QTc Prolongation Used Among Critically Ill Patients
by: Al-Azayzih A, et al.
Published: (2024-02-01)

Ventricular fibrillation due to overdose of loperamide, the “poor man’s methadone”
by: Amr Salama, et al.
Published: (2017-10-01)

Extreme Interocular Asymmetry in an Atypical Case of a Hydroxychloroquine-Related Retinopathy
by: Gabriel Hallali, et al.
Published: (2022-07-01)

The use of Hydroxychloroquine in the Treatment of COVID-19
by: Kamer TECEN-YÜCEL, et al.
Published: (2020-09-01)

Overdrive pacing in the acute management of osimertinib-induced ventricular arrhythmias: A case report and literature review
by: Yanyu Zhang, et al.
Published: (2022-09-01)

The Risk of QTc Prolongation in Non-Diabetic and Diabetic Patients Taking Tyrosine Kinase Inhibitors (TKIs)- A Patient Safety Project at a Private Oncology Practice
by: Zhongju Lu, et al.
Published: (2021-11-01)

Transient Hypogonadism Is Associated With Heart Rate–Corrected QT Prolongation and Torsades de Pointes Risk During Active Systemic Inflammation in Men
by: Pietro Enea Lazzerini, et al.
Published: (2022-01-01)

Sevoflurane prolonged the QTc interval and increased transmural dispersion of repolarization in a patient with long QT syndrome 3: a case report
by: Atsuhiro Kitaura, et al.
Published: (2017-05-01)

Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
by: David M. Stevens, et al.
Published: (2020-12-01)

Hydroxychloroquine/chloroquine prophylaxis among health-care workers: Was it really preventive? – Evidence from a multicentric cross-sectional study
by: Arun Kumar Yadav, et al.
Published: (2022-01-01)

Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study
by: Ruth Fernandez-Ruiz, et al.
Published: (2020-08-01)

Consensus statement on cardiac electrophysiology practices during the coronavirus disease 2019 (COVID-19) pandemic: From the Indian Heart Rhythm Society
by: Narayanan Namboodiri, et al.
Published: (2021-09-01)

SARS-CoV-2 infection in a patient on chronic hydroxychloroquine therapy: Implications for prophylaxis
by: Khalid M. Dousa, et al.
Published: (2020-01-01)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
by: Tzu-Chuan Ho, et al.
Published: (2021-02-01)

Rotatory nystagmus after granisetron administration
by: Abdulelah Shafiq Abualfraj, et al.
Published: (2021-06-01)